Scott J. Garland

Director · 6 filings · Latest: Oct 1, 2026

ALX ONCOLOGY HOLDINGS INC

Day One Biopharmaceuticals, Inc.

Enliven Therapeutics, Inc.

LB PHARMACEUTICALS INC

Olema Pharmaceuticals, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
ELVN	Scott J. Garland	Director	Oct 1, 2026	Sale	$46.67	13,000	$606.7K	0	Oct 5 8:57 PM
ELVN	Scott J. Garland	Director	Oct 1, 2026	Option Exercise	$15.47	13,000	$201.1K	13,000	Oct 5 8:57 PM
ELVN	JEFFREY GARLAND	—	Oct 1, 2026	Proposed Sale	$46.67	13,000	$606.7K	—	Oct 1 8:02 PM